Scholars Central

Conference abstractPublished 23 Sep 2013

Freedom to operate issues and patent litigation considerations for biosimilars

Authors: Sailesh K. Patel

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

This presentation will provide an overview of litigation under the Biologics Price Competition and Innovation Act of 2009 (?Biologics Act?)-An analysis of the intellectual property considerations and hurdles that must be overcome in preparation for litigation under the Biologics Act and launch of a biosimilar product in the United States. This includes a discussion on the types of patents that exist covering a biologic product, patent protection for biosimilars and trade secret issues that must be considered.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Bioanalysis & Biomedicine.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Bioanalysis & Biomedicine
  • BylineArticles whose byline prints “Sailesh K. Patel”